Pulmonary Sarcoidosis

Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)

Also Known As:

Sarcoidosis, Pulmonary; Pulmonary Sarcoidoses; Sarcoidoses, Pulmonary

Respiratory Tract Diseases: 6273
- Lung Diseases: 22701
  - Interstitial Lung Diseases: 8781
    - Pulmonary Sarcoidosis: 1025
Hemic and Lymphatic Diseases: 7
- Lymphatic Diseases: 96
  - Lymphoproliferative Disorders: 4321
    - Sarcoidosis: 8641
      - Pulmonary Sarcoidosis: 1025
Immune System Diseases: 4430
- Hypersensitivity: 78126
  - Delayed Hypersensitivity: 3395
    - Sarcoidosis: 8641
      - Pulmonary Sarcoidosis: 1025

N Bonnemaison Selected Research

N Bonnemaison Research Topics

Disease

Drug/Important Bio-Agent (IBA)